GVHD, Acute

1

Review clinical trials related to GVHD, Acute. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

The purpose of this study is to determine the efficacy and safety of combined Ruxolitinib With Corticosteroids as First Line Therapy for the severe acute GVHD (graft-versus-host disease )

Participants needed: 54
Trial details
Phase: Phase 2Age: 14+Biological sex: AllType: InterventionalSponsor: Daihong LiuUpdated: Apr 3, 2026Locations: 1
Eligibility criteria

diagnosed with hematological diseases. [+2]

Recipients of second allogeneic stem cell transplant. [+11]